Medicinal products

2023/11 - Circular (Pdf, 205 Kb) on the replacement of MEPHENON 5mg with METHASAN 40 mg 

2018/10 - Note (Pdf, 518 Kb) on products derived from cannabis and hemp

Medical cannabis apart, a number of products, advertised as containing cannabidiol (CBD), have recently appeared on the Luxembourg market. Like delta-9-tetrahydrocannabinol (THC), CBD is one of the major active constituents of cannabis, also known as hemp. CBD has no psychoactive effects, unlike tetrahydrocannabinols, which are listed in the schedule of narcotic substances[1]. As such, the use of tetrahydrocannabinols is strictly controlled. Among the products advertised as containing low-THC, high-CBD cannabis varieties, are e-liquids for electronic cigarettes, cosmetics, and capsules and food products. As such, the pubic health authorities would like to provide some clarification on the regulations that apply to these products. According to Luxembourg legislation, all operations involving cannabis are forbidden, including growing, possessing, and using cannabis[2]. Accordingly, any product that contains cannabidiol derived from cannabis is forbidden, unless it is subject to exemption, as described below[3]. Finished products that contain THC, regardless of the amount, are forbidden. Products such as e-liquids based on CBD are forbidden if they contain THC, regardless of the amount, and if the CDB is not obtained from authorised cannabis varieties and plant parts. Lastly, some advertisements that promote CBD-containing products capitalise on the confusion between cannabis and CBD, which means that they are actually promoting cannabis. This practice is likely to constitute an offence within the meaning of the Law of 19 February 1973, as amended, on the sale of medicinal substances and the fight against drug addiction. [1]Grand Ducal regulation of 4 March 1974 on certain toxic substances; [2] Article 7 of the Law of 19 February 1973 on the sale of medicinal substances and the fight against drug addiction; [3] Article 1 of the Grand Ducal regulation of 26 March 1974 establishing the schedule of narcotics